All results
124 results for impact
-
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon…
- Ages
- N/A - N/A
- Sexes
- All
-
Lactobacillus johnsonii N6.2 in children and adolescents with T1D
While genetics demonstrated a major risk factor for the development of type 1 diabetes (T1D), microbiota dysbiosis has been suggested as an elicitor in…
- Ages
- 8 Years - 18 Years
- Sexes
- All
-
HEAL-IST
Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
L. johnsonii in adult with T1D
While genetics demonstrated a major risk factor for the development of type 1 diabetes (T1D), microbiota dysbiosis has been suggested as an elicitor in…
- Ages
- 18 Years - 45 Years
- Sexes
- All
-
EN20-01
The primary objective of this study is to evaluate the safety and efficacy of CNTX-6970 for the treatment of pain related to OA of the knee compared to…
- Ages
- 40 Years - 90 Years
- Sexes
- All
-
ADOPT PGx
This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and…
- Ages
- 8 Years - N/A
- Sexes
- All
-
Microfluidics
Sepsis has its greatest impact in the prematurely born (preterm) population. Neonatal sepsis (sepsis within the first month of life) causes over one million…
- Ages
- 23 Weeks - 42 Weeks
- Sexes
- All
-
BEACH
The impact of breastfeeding on the infant microbiome in vaginally and Cesarean delivered offspring from obese and normal weight mothers. **Design:** Normal…
- Ages
- 18 Years - 45 Years
- Sexes
- Female
-
Biopsychosocial Influence on Shoulder Pain
Chronic shoulder pain is a common, costly, and disabling problem for society. The identification of factors predictive of the development of chronic shoulder…
- Ages
- 18 Years - 64 Years
- Sexes
- All
-
mFOLFIRINOX vs. FOLFOX With Nivolumab for First-Line Tx of Metastatic HER2- GE Adendocarcinoma
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil,…
- Ages
- 18 Years - N/A
- Sexes
- All